Study Says Hydroxychloroquine Doesn’t Cure COVID-19 and Raises Death Risk, But Trump Keeps Promoting It
“Treatment with chloroquine or hydroxychloroquine does not benefit patients with COVID-19,” says Mandeep Mehra, lead author of a new study that was published in The Lancet medical journal.
Mehra, executive director of the Brigham and Women’s Hospital Center for Advanced Heart Disease in Boston, and his team studied the medical records of 96,000 patients across hundreds of hospitals found no benefit in treating them with anti-viral drugs hydroxychloroquine and chloroquine, and even increased the likelihood of them dying, notes AFP.
Only nine percent of the patients who did not take any hydroxychloroquine died, while 18 percent of those treated with hydroxychloroquine died, and 16.4 percent of those treated with chloroquine died.
A staggering 22.8 percent of patients given chloroquine in combination with antibiotics died, and 23.8 percent given hydroxychloroquine in combination with antibiotics died.
President Donald Trump recently claimed that he had been taking hydroxychloroquine, even though the White House doctor refused to confirm Trump’s claim. The Food and Drug Administration warns against using the drug for COVID-19, but does allow doctors to prescribe it.
Both chloroquine or hydroxychloroquine can produce potentially serious side effects, including heart arrhythmia.
Frank Ruschitzka, director of the Heart Center at University Hospital Zurich and co-author of the study, warned that countries are using hydroxychloroquine as a supposed cure for the coronavirus:
Several countries have advocated use of chloroquine and hydroxychloroquine, either alone or in combination, as potential treatments for COVID-19. We now know from our study that the chance that these medications improve outcomes in COVID-19 is quite low.